Ordaos

Ordaōs is a human-enabled, machine-driven drug design company that uses generative AI to create novel mini-proteins (miniPRO) for targeted drug therapies. The company's proprietary AI engine designs bespoke mini-proteins to help drug hunters deliver treatments that reduce patient suffering and cure without harm. Ordaōs focuses on overlooked patient populations and diseases underserved by traditional drug discovery. Backed by Johnson & Johnson Innovation (JLABS).